Sonya N. Wright

Array ( [id] => 6751197 [patent_doc_number] => 20030045718 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'Crystalline salts of 7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3r,5s)-3,5-dihydroxyhept-6-enoic acid' [patent_app_type] => new [patent_app_number] => 10/203890 [patent_app_country] => US [patent_app_date] => 2002-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 5955 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20030045718.pdf [firstpage_image] =>[orig_patent_app_number] => 10203890 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1586180 [patent_doc_number] => 06358962 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-03-19 [patent_title] => '6,7-Dimethoxyquinazolines and therapeutic use thereof' [patent_app_type] => B2 [patent_app_number] => 09/779809 [patent_app_country] => US [patent_app_date] => 2001-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 42 [patent_no_of_words] => 19676 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/358/06358962.pdf [firstpage_image] =>[orig_patent_app_number] => 09779809 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6893841 [patent_doc_number] => 20010016207 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-08-23 [patent_title] => 'Dipeptide nitrile cathepsin K inhibitors' [patent_app_type] => new [patent_app_number] => 09/778302 [patent_app_country] => US [patent_app_date] => 2001-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9873 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20010016207.pdf [firstpage_image] =>[orig_patent_app_number] => 09778302 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 953929 [patent_doc_number] => 06958343 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-10-25 [patent_title] => 'Thiazolopyrimidines and their use as modulators of chemokine receptor activity' [patent_app_type] => utility [patent_app_number] => 10/203580 [patent_app_country] => US [patent_app_date] => 2001-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7791 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/958/06958343.pdf [firstpage_image] =>[orig_patent_app_number] => 10203580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1419911 [patent_doc_number] => 06514962 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-04 [patent_title] => 'Stabilized preparations of -lactam antibiotic' [patent_app_type] => B1 [patent_app_number] => 09/774186 [patent_app_country] => US [patent_app_date] => 2001-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1561 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/514/06514962.pdf [firstpage_image] =>[orig_patent_app_number] => 09774186 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6948077 [patent_doc_number] => 20010021713 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-09-13 [patent_title] => 'Thromboresistant materials incorporating pyrazinone protease inhibitors' [patent_app_type] => new [patent_app_number] => 09/773730 [patent_app_country] => US [patent_app_date] => 2001-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22219 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20010021713.pdf [firstpage_image] =>[orig_patent_app_number] => 09773730 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1096357 [patent_doc_number] => 06821965 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-11-23 [patent_title] => 'Amidobenzamide derivatives which are useful as cytokine inhibitors' [patent_app_type] => B1 [patent_app_number] => 09/762106 [patent_app_country] => US [patent_app_date] => 2001-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33517 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1804 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/821/06821965.pdf [firstpage_image] =>[orig_patent_app_number] => 09762106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1291612 [patent_doc_number] => 06630471 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-07 [patent_title] => 'Substituted triazolo-pyridazine derivative, pharmaceutical compositions made therefrom' [patent_app_type] => B1 [patent_app_number] => 09/719184 [patent_app_country] => US [patent_app_date] => 2001-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10346 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/630/06630471.pdf [firstpage_image] =>[orig_patent_app_number] => 09719184 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6158908 [patent_doc_number] => 20020147178 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-10 [patent_title] => '6- (spirocyclopropyl) penicillanic acid 4, 4-dioxides' [patent_app_type] => new [patent_app_number] => 09/771440 [patent_app_country] => US [patent_app_date] => 2001-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9861 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20020147178.pdf [firstpage_image] =>[orig_patent_app_number] => 09771440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5969004 [patent_doc_number] => 20020091078 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-11 [patent_title] => 'Tetrahydropyrimidone inhibitors of fatty acid binding protein and method' [patent_app_type] => new [patent_app_number] => 09/771310 [patent_app_country] => US [patent_app_date] => 2001-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29051 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20020091078.pdf [firstpage_image] =>[orig_patent_app_number] => 09771310 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5802254 [patent_doc_number] => 20020010185 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-24 [patent_title] => 'Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof' [patent_app_type] => new [patent_app_number] => 09/769420 [patent_app_country] => US [patent_app_date] => 2001-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 19041 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20020010185.pdf [firstpage_image] =>[orig_patent_app_number] => 09769420 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6175676 [patent_doc_number] => 20020155443 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-24 [patent_title] => 'Metal binding DNA interactive compounds' [patent_app_type] => new [patent_app_number] => 09/771016 [patent_app_country] => US [patent_app_date] => 2001-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 36802 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20020155443.pdf [firstpage_image] =>[orig_patent_app_number] => 09771016 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6408586 [patent_doc_number] => 20020037901 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-28 [patent_title] => 'Thiazolidinecarboxyl acids' [patent_app_type] => new [patent_app_number] => 09/767306 [patent_app_country] => US [patent_app_date] => 2001-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5952 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20020037901.pdf [firstpage_image] =>[orig_patent_app_number] => 09767306 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6308261 [patent_doc_number] => 20020095044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-18 [patent_title] => 'Inhibitors of inflammation and reperfusion injury and methods of use thereof' [patent_app_type] => new [patent_app_number] => 09/766053 [patent_app_country] => US [patent_app_date] => 2001-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10503 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0095/20020095044.pdf [firstpage_image] =>[orig_patent_app_number] => 09766053 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1005475 [patent_doc_number] => 06906072 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-06-14 [patent_title] => 'Piperazine compound and pharmaceutical composition containing the compound' [patent_app_type] => utility [patent_app_number] => 10/169837 [patent_app_country] => US [patent_app_date] => 2001-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 79620 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/906/06906072.pdf [firstpage_image] =>[orig_patent_app_number] => 10169837 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7079380 [patent_doc_number] => 20010041797 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-15 [patent_title] => 'Processes for preparing substituted 1, 3-oxathiolanes with antiviral properties' [patent_app_type] => new [patent_app_number] => 09/760380 [patent_app_country] => US [patent_app_date] => 2001-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11515 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20010041797.pdf [firstpage_image] =>[orig_patent_app_number] => 09760380 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1333367 [patent_doc_number] => 06596721 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-07-22 [patent_title] => 'Stable crystalline (6R) -tetrahydrofolic acid' [patent_app_type] => B2 [patent_app_number] => 09/755072 [patent_app_country] => US [patent_app_date] => 2001-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4145 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/596/06596721.pdf [firstpage_image] =>[orig_patent_app_number] => 09755072 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1392917 [patent_doc_number] => 06544995 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-08 [patent_title] => 'Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric G protein' [patent_app_type] => B1 [patent_app_number] => 09/743208 [patent_app_country] => US [patent_app_date] => 2001-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 8649 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/544/06544995.pdf [firstpage_image] =>[orig_patent_app_number] => 09743208 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 946699 [patent_doc_number] => 06965033 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-11-15 [patent_title] => 'Bisamidate phosphonate prodrugs' [patent_app_type] => utility [patent_app_number] => 09/747182 [patent_app_country] => US [patent_app_date] => 2000-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 96736 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/965/06965033.pdf [firstpage_image] =>[orig_patent_app_number] => 09747182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6439864 [patent_doc_number] => 20020128269 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-12 [patent_title] => 'Substituted heterocyclic compounds for treating multidrug resistance' [patent_app_type] => new [patent_app_number] => 09/740387 [patent_app_country] => US [patent_app_date] => 2000-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15304 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20020128269.pdf [firstpage_image] =>[orig_patent_app_number] => 09740387 [rel_patent_id] =>[rel_patent_doc_number] =>)